- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00569439
A Study on the Effects of Dextrose Solutions on the Course of Labor
A Randomized Controlled Trial Comparing Normal Saline With and Without Dextrose on the Course of Labor in Nulliparas
Study Overview
Detailed Description
Factors that affect the course of labor have been studied extensively. Surprisingly, there is little data on the effect that different types and rates of intravenous (IV) fluids have during labor. Exercise physiologists have shown that increased fluid intake and carbohydrate replacement improve skeletal muscle performance in prolonged exercise. In a 1992 randomized, controlled study comparing IV fluid rates, Garite et al. showed a lower frequency of prolonged labor, and possibly a decreased need for oxytocin, with higher IV fluid rates in labor. Inadequate hydration may contribute to dysfunctional labor and possibly an increased rate of cesarean section.
We propose that inadequate carbohydrate replacement in labor may also contribute to prolongation of labor and increased need for operative delivery. Glucose is the main energy supply for the pregnant uterus. Physiological requirements for glucose during labor are approximately 10 grams per hour. Adequate supplies of glucose are needed to maintain exercise tolerance and muscle efficiency, which are important factors in the progress of labor. Dysfunctional labor or dystocia, which is the leading indication for primary cesarean delivery, is caused by uterine forces insufficiently strong or inappropriately coordinated to efface and dilate the cervix. Dystocia can also be a result of inadequate voluntary muscle effort in the second stage of labor. It contributes to increased risk for chorioamnionitis, which is a leading cause of maternal and fetal morbidity and mortality. Supplying carbohydrate fuel for working uterine and skeletal muscle may improve progress in labor and, therefore, diminish risk for chorioamnionitis and need for cesarean delivery.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- Primiparous
- Singleton gestation
- Vertex presentation
- Spontaneous active labor with or without pitocin augmentation
- Gestational age > 36 weeks
- Cervical dilation 3 to 5 cm with or without ruptured membranes
Exclusion Criteria:
- Multiparous
- Pregestational or gestational diabetes mellitus
- Preeclampsia at admission
- Previous cesarean section
- Non-vertex presentation
- Multiple gestation
- Chorioamnionitis at admission
- Intrauterine growth restriction (< 10th percentile)
- Patients admitted for induction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: D5
5% Dextrose Solution in Normal Saline
|
5% Dextrose in Normal Saline (6.25 gr/hr) at 125 cc/hr
|
Experimental: D10
|
10% Dextrose Solution (12.5 gr/h) in Normal Saline at 125 cc/hr
|
Placebo Comparator: NS
|
Normal Saline solution at 125 cc/hr
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Carbohydrate solutions can decrease the total duration of labor by 20% (from 560 minutes to 450 minutes)
Time Frame: Prospective
|
Prospective
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Carbohydrate solutions can decrease the incidence of prolonged labor (> 12 hours
Time Frame: Prospective
|
Prospective
|
Carbohydrate solutions can decrease the incidence of chorioamnionitis during labor
Time Frame: Prospective
|
Prospective
|
Carbohydrate solutions can decrease the need for oxytocin (a contraction stimulant) augmentation of labor
Time Frame: Prospective
|
Prospective
|
Carbohydrate solutions can decrease the frequency of cesarean sections for prolonged labor
Time Frame: Prospective
|
Prospective
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kenneth Chan, M.D., Memorial Care
- Principal Investigator: Sherri Jenkins, M.D., University of Alabama At Birmingham
- Principal Investigator: Thomas J. Garite, M.D., University of California, Irvine
Study record dates
Study Major Dates
Study Start
Primary Completion
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 035-00
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor
-
University Hospital, GenevaQIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia ACCompletedLabor Onset | Labor, Induced | Labor, Obstetric | Predictive ModelSwitzerland
-
MemorialCare Health SystemCompletedLength of Labor | Second Stage of Labor | Intravenous Hydration of LaborUnited States
-
Raed SalimCompleted
-
University of RochesterJuniper Pharmaceuticals, Inc.WithdrawnLabor, PrematureUnited States
-
HaEmek Medical Center, IsraelCompleted
-
CAMC Health SystemCompleted
-
Hospital Clinic of BarcelonaCompletedThreatened Premature LaborSpain
-
Oslo University HospitalCompletedLabor (Obstetrics)--Complications | Labor; Prolonged, First StageNorway
-
University of TennesseeRecruitingLabor Onset and Length Abnormalities | Labor Long | Prolonged Labor | Labor; PoorUnited States
-
Hospital Miguel ServetCompletedPregnancy | Obstetric Labor | Cervical Ripening | Induced Labor
Clinical Trials on D5NS
-
Children's Hospital of PhiladelphiaAmerican Academy of Pediatrics; Academic Pediatric AssociationCompleted
-
University of SaskatchewanCompletedPostoperative VomitingCanada